To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Kohlberg recaps CRO Worldwide Clinical Trials
TJC, which has been Worldwide’s sole investor since 2007, retains a meaningful minority equity stake in the CRO.
